Alliance for regenerative rehabilitation and training receives $5 million NIH grant
PITTSBURGH, July 13,2020 – The National Institutes of Health (NIH) has renewed a five-year grant for $5 million for the Alliance for Regenerative Rehabilitation and Training (AR3T) to continue its work expanding scientific knowledge, expertise and methodologies focused on science and regenerative medicine. AR3T is a multi-institutional network of laboratories at the University of Pittsburgh, Stanford University, Mayo Clinic and the University of Texas at Austin.
“The research we have supported has launched exciting new collaborations and innovative lines of investigation, which have led to numerous publications and larger-scale grants,” said Fabrisia Ambrosio, Ph.D., M.P.T., associate professor, Department of Physical Medicine and Rehabilitation, Pitt School of Medicine. “With this new grant cycle, we plan to build upon our previous successes while continuously adapting to better meet the changing needs of our community. We will do this through an online webinar series, a junior scholars program, pilot funding incubator programs and so much more.”
AR3T integrates regenerative medicine with rehabilitative medicine to increase the efficacy of interventions designed to help people with disabilities be more independent and engaged. AR3T has reached experts in the spinal cord, orthopaedic, regenerative medicine, rehabilitation, neuroscience, sports medicine and exercise research, military health and clinician communities.
“At its core, AR3T exists to promote collaboration,” added Ambrosio. “We help create new connections that have the potential to lead to the next breakthroughs in regenerative rehabilitation research. The long-term goal is to convert these research advances into meaningful therapeutic options for our patients.”
In addition to Ambrosio, Michael Boninger, M.D., professor, Department of Physical Medicine and Rehabilitation, Pitt School of Medicine, and Thomas A. Rando, M.D., Ph.D., professor, Department of Neurology and Neurological Sciences at Stanford University, are the co-principal investigators.
The NIH grant number is 2P2CHD086843-06.
To read this release online or share it, visit https:/
About the University of Pittsburgh School of Medicine
As one of the nation’s leading academic centers for biomedical research, the University of Pittsburgh School of Medicine integrates advanced technology with basic science across a broad range of disciplines in a continuous quest to harness the power of new knowledge and improve the human condition. Driven mainly by the School of Medicine and its affiliates, Pitt has ranked among the top 10 recipients of funding from the National Institutes of Health since 1998. In rankings recently released by the National Science Foundation, Pitt ranked fifth among all American universities in total federal science and engineering research and development support.
Likewise, the School of Medicine is equally committed to advancing the quality and strength of its medical and graduate education programs, for which it is recognized as an innovative leader, and to training highly skilled, compassionate clinicians and creative scientists well-equipped to engage in world-class research. The School of Medicine is the academic partner of UPMC, which has collaborated with the University to raise the standard of medical excellence in Pittsburgh and to position health care as a driving force behind the region’s economy. For more information about the School of Medicine, see http://www.
Contact: Sheila Davis